Without going back to the video. My takeout was the comment “continuing to produce antibodies “. With T cell immunotherapy antibodies costing a bomb . Whereas with B Cell vaccines, the initial injection keeps the spleen producing antibodies for a period of time. Combined with the checkpoint blockers, the body does not block the antibodies. So the therapy “keeps on keeping on” just like the paint.
IMU products have super low cost base . IMU has developed its own combo therapy , which IMU has a monopoly on, that’s where the Gold is buried... These vaccines would only cost cents to make in volume. From what we have been told IMU’s B cell therapy works better without chemo destroying the immune response first.
That’s what will get presented at this conference. Imagine a company presenting at such a prestigious conference showing they have a very cheap combo therapy, WITHOUT SIDE EFFECTS OR TOXICITY, that continues to produce antibodies for 56 days after injection, that’s supersedes chemo.
Will that get some attention from big bio and big Pharma? Will they go early for a deal?
(20min delay)
